Collectively, tau and Aβ act as synergistic drivers of neurodegeneration in PD, providing a mechanistic substrate for the cognitive impairment seen in patients with mixed protein-aggregation disorder [11,53,54]. The gene discussed is MAPT; the disease is Parkinson disease.